Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Albemarle Corporation

ALBNYSE
Basic Materials
Chemicals - Specialty
$177.52
$9.10(5.40%)
U.S. Market opens in 8h 24m

Albemarle Corporation Fundamental Analysis

Albemarle Corporation (ALB) shows weak financial fundamentals with a PE ratio of -40.40, profit margin of -9.93%, and ROE of -5.13%. The company generates $5.1B in annual revenue with weak year-over-year growth of -44.08%.

Key Strengths

PEG Ratio0.15
Current Ratio2.23

Areas of Concern

ROE-5.13%
Operating Margin1.73%
We analyze ALB's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -21.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-21.3/100

We analyze ALB's fundamental strength across five key dimensions:

Efficiency Score

Weak

ALB struggles to generate sufficient returns from assets.

ROA > 10%
-3.12%

Valuation Score

Excellent

ALB trades at attractive valuation levels.

PE < 25
-40.40
PEG Ratio < 2
0.15

Growth Score

Weak

ALB faces weak or negative growth trends.

Revenue Growth > 5%
-44.08%
EPS Growth > 10%
-1.84%

Financial Health Score

Excellent

ALB maintains a strong and stable balance sheet.

Debt/Equity < 1
0.35
Current Ratio > 1
2.23

Profitability Score

Weak

ALB struggles to sustain strong margins.

ROE > 15%
-513.22%
Net Margin ≥ 15%
-9.93%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is ALB Expensive or Cheap?

P/E Ratio

ALB trades at -40.40 times earnings. This suggests potential undervaluation.

-40.40

PEG Ratio

When adjusting for growth, ALB's PEG of 0.15 indicates potential undervaluation.

0.15

Price to Book

The market values Albemarle Corporation at 2.16 times its book value. This may indicate undervaluation.

2.16

EV/EBITDA

Enterprise value stands at 25.31 times EBITDA. This signals the market has high growth expectations.

25.31

How Well Does ALB Make Money?

Net Profit Margin

For every $100 in sales, Albemarle Corporation keeps $-9.93 as profit after all expenses.

-9.93%

Operating Margin

Core operations generate 1.73 in profit for every $100 in revenue, before interest and taxes.

1.73%

ROE

Management delivers $-5.13 in profit for every $100 of shareholder equity.

-5.13%

ROA

Albemarle Corporation generates $-3.12 in profit for every $100 in assets, demonstrating efficient asset deployment.

-3.12%

Following the Money - Real Cash Generation

Operating Cash Flow

Albemarle Corporation produces operating cash flow of $1.28B, showing steady but balanced cash generation.

$1.28B

Free Cash Flow

Albemarle Corporation generates strong free cash flow of $693.32M, providing ample flexibility for dividends, buybacks, or growth.

$693.32M

FCF Per Share

Each share generates $5.88 in free cash annually.

$5.88

FCF Yield

ALB converts 3.31% of its market value into free cash.

3.31%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-40.40

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.15

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.16

vs 25 benchmark

P/S Ratio

Price to sales ratio

4.02

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.35

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.23

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.05

vs 25 benchmark

ROA

Return on assets percentage

-0.03

vs 25 benchmark

ROCE

Return on capital employed

0.006

vs 25 benchmark

How ALB Stacks Against Its Sector Peers

MetricALB ValueSector AveragePerformance
P/E Ratio-40.4027.01 Better (Cheaper)
ROE-5.13%949.00% Weak
Net Margin-9.93%-16159.00% (disorted) Weak
Debt/Equity0.350.48 Strong (Low Leverage)
Current Ratio2.234.42 Strong Liquidity
ROA-3.12%-6411.00% (disorted) Weak

ALB outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Albemarle Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

35.07%

Industry Style: Cyclical, Commodity, Value

High Growth

EPS CAGR

-299.42%

Industry Style: Cyclical, Commodity, Value

Declining

FCF CAGR

-12.01%

Industry Style: Cyclical, Commodity, Value

Declining

Fundamental Analysis FAQ